Company: RENEF
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0001410578-25-000584
Chunk: 24

Company: Cartesian Growth Corp II
Filing Date: 2025-03-31
Form: 10-K
Item: Item 1B
Chunk 24
---
 sale of the private placement warrants and the sponsor loan, was placed in the trust account. Transaction costs of the initial public offering amounted to $16,804,728, consisting of $4,600,000 of underwriting commissions, $11,500,000 of deferred underwriting commissions and $704,728 of other offering costs.

Class B Conversion

On September 22, 2023, in accordance with the provisions of our amended and restated memorandum and articles of association the sponsor and directorCo exercised their rights to convert an aggregate of 5,749,998 Class B ordinary shares into an equal number of Class A ordinary shares, on a one-for-one basis (the “Class B Conversion”). As a result of the Class B Conversion, at December 31, 2024, there were 21,620,559 Class A ordinary shares and two Class B ordinary shares issued and outstanding.

First Extension

On November 6, 2023, our shareholders approved an amendment to our amended and restated memorandum and articles of association (the “First Extension Charter Amendment”). The First Extension Charter Amendment extended the date by which we had to consummate a business combination for up to an additional twelve months, from November 10, 2023 to up to November 10, 2024, by electing to extend the date to consummate an initial business combination on a monthly basis for up to twelve times by an additional one month each time, unless the closing of the Company’s initial business combination has occurred (which we refer to as the “First Extension” and such applicable later date, the “First Extended Date”), without the need for any further approval of our shareholders, provided that the sponsor (or its affiliates or permitted designees) deposited into the trust account for each such one-month extension (the “First Charter Amendment Extension Payments”) the lesser of (a) an aggregate of $150,000 and (b) $0.02 per public share that remained outstanding and was not redeemed prior to any such one-month extension, in exchange for a non-interest bearing promissory note payable upon consummation of an initial business combination.